Shanghai Argo Biopharmaceutical Co., Ltd.

This study is testing whether a new injectable drug called BW-00112 can safely lower high levels of triglycerides and other fats in the blood of people with mixed dyslipidemia. About 145 participants, who are already taking a stable dose of a statin medication, will receive eithe…

This study is testing whether a new injection called BW-20507, when given alongside a standard Hepatitis B drug (pegylated interferon), is safe and effective at controlling the virus. It involves 209 adults with chronic Hepatitis B who meet specific health criteria. The main goal…

This study is testing an investigational drug called BW-20805 to see if it can safely reduce the number of swelling attacks in adults with hereditary angioedema (HAE). Researchers will measure how much the monthly attack rate decreases over about 6 months of treatment. The trial …